Overview

NEUROIMPA - Intraarticular Application of Opioids in Chronic Arthritis of the Knee Joint

Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
To investigate pain and inflammatory parameters (cytokines, immune cells) in knee joint tissue of chronic arthritis patients following intraarticular (i.a.) injections of morphine, a standard steroid or placebo. The primary hypothesis is that i.a. morphine results in significantly lower pain scores and supplemental analgesic consumption than placebo during the first week after injection, an efficacy comparable to standard i.a. steroid (triamcinolone) medication.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Hildrun Haibel
Collaborator:
DLR German Aerospace Center
Treatments:
Morphine
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide